AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Aug 11, 2016

30071_dirs_2016-08-11_50229beb-e997-45d1-a50f-c0caeb260cb1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-08-11

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-11	ResMed Common Stock	S	35000	$70.50	Disposed	51084	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $70.22 to $70.79. The price reported above reflects the weighted average sale price.

F2: Restated balance to correct duplicate reporting of 33,473 shares vested 11/11/2014.

F3: Includes 229.81 shares of ResMed stock purchased on May 5, 2016, through the ResMed Employee Stock Purchase Plan.